The objective of the proposed research is to elucidate the cellular mechanism by which vasopressin (VP) regulates tubular luminal membranes of mammalian kidney in health and disease. The major focus will be on elucidation of biochemical mechanism by which cyclic AMP (cAMP), generated in response to VP, regulates function of luminal plasma membranes (""""""""post cAMP steps""""""""). Studies will be conducted on two segments of tubules both regulated by VP via cAMP, but with different functional responses of luminal membranes: on collecting tubules and ducts and on ascending limb of Henle's loop. The specific objectives include: 1. To determine the localization, subcellular distribution and regulatory properties of the major enzymes and modulators of the cAMP-dependent protein phosphorylation system. We will study in particular: a) isoenzymes of cAMP-dependent protein kinases, b) protein phosphatases and c) non-enzymatic protein modulators. 2. To examine VP-regulated phosphorylations of endogenous substrates in intact tubules. Proteins and/or glycoproteins which are phosphorylated in response to increases in cAMP will be identified. Specifically, we will examine the relationship of cAMP-dependent endogenous phosphorylations to components of cytoskeleton, namely microtubules and microfilaments, calcium-calmodulin dependent proteins, and to components of luminal plasma membranes of collecting tubules and ducts. 3. To identify basic biochemical components of luminal plasma membranes of collecting tubules and ducts, we will use radiolabeled non-penetrating covalent chemical probes. Further, we will determine specific biochemical changes elicited by VP via cAMP in these membranes. 4. To study the """"""""post cAMP"""""""" components in animal models of both hyporesponsiveness and hyperresponsiveness to VP. Nephrogenic diabetes insipidus and a model of hyperresponsiveness to VP induced by administration of chlorpropamide will be studied to elucidate the pathogenesis of these dysfunctions. The studies will be conducted on renal tubules microdissected from normal rats, rabbits and mice or from animals with hereditary or drug-induced urinary concentrating defects.

Project Start
1975-01-01
Project End
1987-12-31
Budget Start
1985-04-01
Budget End
1985-12-31
Support Year
14
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Kusano, E; Yusufi, A N; Murayama, N et al. (1986) Dynamics of nucleotides in distal nephron of mice with nephrogenic diabetes insipidus. Am J Physiol 250:F151-8
Murayama, N; Ruggles, B T; Gapstur, S M et al. (1985) Evidence for beta adrenoceptors in proximal tubules. Isoproterenol-sensitive adenylate cyclase in pars recta of canine nephron. J Clin Invest 76:474-81
Dousa, T P; Christensen, S; Kusano, E et al. (1985) Lithium, cyclic AMP and renal pathophysiology. Acta Pharmacol Toxicol (Copenh) 56 Suppl 1:180-9
Turner, S T; Dousa, T P (1985) Phosphate transport by brushborder membranes from superficial and juxtamedullary cortex. Kidney Int 27:879-85
Kusano, E; Murayama, N; Werness, J L et al. (1985) Effects of calcium on the vasopressin-sensitive cAMP metabolism in medullary tubules. Am J Physiol 249:F956-66
Christensen, S; Kusano, E; Yusufi, A N et al. (1985) Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest 75:1869-79
Ruggles, B T; Murayama, N; Werness, J L et al. (1985) The vasopressin-sensitive adenylate cyclase in collecting tubules and in thick ascending limb of Henle's loop of human and canine kidney. J Clin Endocrinol Metab 60:914-21
Kiebzak, G M; Yusufi, A N; Kusano, E et al. (1985) ATP and cAMP system in the in vitro response of microdissected cortical tubules to PTH. Am J Physiol 248:F152-9